...facto standard," he said. The last biotech to go public in Japan was cancer company GreenPeptide Co. Ltd.... ...¥2.9 billion ($24.3 million) in an IPO on Mothers in October 2015. At the time, GreenPeptide...
...hopes for a couple of biotechs in particular, such as Sosei Group, PeptiDream, Acucela and GreenPeptide... ...signaled those plans in December and expects to complete the process in September or October. GreenPeptide Co. Ltd.... ...gain of more than 200% in 1Q16 after languishing in 2015 following its October IPO. GreenPeptide's...
...facto standard," he said. The last biotech to go public in Japan was cancer company GreenPeptide Co. Ltd.... ...¥2.9 billion ($24.3 million) in an IPO on Mothers in October 2015. At the time, GreenPeptide...
...hopes for a couple of biotechs in particular, such as Sosei Group, PeptiDream, Acucela and GreenPeptide... ...signaled those plans in December and expects to complete the process in September or October. GreenPeptide Co. Ltd.... ...gain of more than 200% in 1Q16 after languishing in 2015 following its October IPO. GreenPeptide's...